A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Public ClinicalTrials.gov record NCT07609719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Single-arm Study of Ocrelizumab Administered Subcutaneously in Patients With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Study identification
- NCT ID
- NCT07609719
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- OCR SC Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 16, 2026
- Primary completion
- Feb 27, 2029
- Completion
- Feb 27, 2029
- Last update posted
- Jul 5, 2026
2026 – 2029
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Neurology Associates | Birmingham | Alabama | 35209 | — |
| Clinical Endpoints | Scottsdale | Arizona | 85258 | — |
| Advanced Neurology of Colorado | Fort Collins | Colorado | 80528 | — |
| Neurology Associates - Maitland | Orlando | Florida | 32751 | — |
| Multiple Sclerosis Center of Atlanta/Atlanta Neuroscience Institute | Atlanta | Georgia | 30327 | — |
| Minneapolis Clinic of Neurology | Minneapolis | Minnesota | 55422 | — |
| Ohio State University, Multiple Sclerosis and Neuroimmunology Center | Columbus | Ohio | 43210 | — |
| Neurology Clinic, P.C. | Cordova | Tennessee | 38018 | — |
| DHR Health MS Center | McAllen | Texas | 78501 | — |
| MultiCare Institute for Research & Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07609719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 5, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07609719 live on ClinicalTrials.gov.